Gastrointestinal Devices Market Size & Forecast Report - 2025 to 2030

The global gastrointestinal devices market size was valued at over USD 12 billion in 2024 and expected to grow at a significant CAGR of around 6.5% during the forecast period from 2025 to 2030. The market is benefiting from the growing preference for outpatient and ambulatory surgical centers due to their cost-effectiveness and reduced hospital stays. The increasing awareness of early disease detection and the expansion of healthcare infrastructure in emerging economies are creating lucrative growth opportunities for manufacturers. However, challenges such as high device costs, regulatory hurdles, and the need for skilled professionals may slightly restrain market expansion. Nonetheless, with continuous R&D investments and the integration of robotics and AI in gastrointestinal procedures, the market is expected to experience steady growth in the coming years.

The market encompasses a wide range of medical instruments and systems designed for the diagnosis, treatment, and monitoring of gastrointestinal disorders affecting the esophagus, stomach, intestines, and related organs. Key devices include endoscopes, capsule endoscopy systems, stents, biopsy forceps, hemostasis devices, and feeding tubes. Market growth is primarily fueled by the rising prevalence of gastrointestinal diseases such as colorectal cancer, gastroesophageal reflux disease (GERD), and inflammatory bowel disease (IBD), coupled with an aging population that is more susceptible to digestive disorders. Technological advancements—such as high-definition imaging, minimally invasive procedures, and AI-assisted endoscopic diagnostics—are further enhancing efficiency and patient outcomes, driving higher adoption rates across healthcare facilities.

Market Drivers in the Global Gastrointestinal Devices Market:

The gastrointestinal devices market continues to be powered by a dual force: rising disease burden and shifting preferences toward minimally invasive diagnostics. Digestive disorders such as colorectal cancer, IBD, and GERD are growing globally due to factors like aging populations, sedentary lifestyles, and dietary changes. This trend amplifies demand for advanced endoscopic tools, capsule systems, and biopsy instruments. In tandem, clinicians and patients increasingly favor outpatient procedures that reduce recovery time and complications. Recent technological breakthroughs—like Multi-Contrast Laser Endoscopy (MLE), which enhances lesion visibility by up to threefold in colonoscopies compared to traditional imaging—underscore this momentum toward precision diagnostics and improved patient outcomes.

Innovation aside, regulatory evolution is shaping market dynamics significantly. In April 2025, the U.S. Food and Drug Administration (FDA) granted authorization for the novel Rectal Expulsion Device (RED), developed at the University of Michigan. This device enables primary care providers to quickly diagnose chronic constipation and determine whether patients would benefit from physical therapy rather than prolonged laxative use or specialist referrals, accelerating treatment decision-making. These advancements—both in imaging technology and streamlined diagnostic tools—highlight how R&D combined with thoughtful regulation is enabling more accurate, accessible GI care and stimulating market growth.

Market Snapshot:

Market Trends Shaping the Global Gastrointestinal Devices Market

AI and Machine Learning Integration

Artificial intelligence (AI) and machine learning are rapidly transforming gastrointestinal diagnostics by enhancing the accuracy and speed of procedures such as colonoscopies and endoscopies. These systems can analyze video feeds in real time, automatically flagging suspicious lesions, polyps, or ulcers for the physician’s review. Platforms like Medtronic’s GI Genius and Fujifilm’s AI-enabled endoscopy tools have demonstrated measurable improvements in detection rates. The technology not only reduces the risk of missed diagnoses but also shortens procedure time, making it possible to treat more patients efficiently.

Shift Toward Minimally Invasive & Outpatient Procedures

There is a growing patient and physician preference for procedures that are less invasive, require smaller incisions, and can be performed in outpatient or ambulatory care settings. Technologies such as capsule endoscopy—where patients swallow a small camera that transmits images of the digestive tract—and robotic-assisted endoscopic surgeries are becoming popular. These approaches minimize recovery times, lower post-procedure complications, and are generally more comfortable for patients. This shift is also driven by healthcare cost pressures, as outpatient care tends to be more affordable than inpatient hospitalization.

Single-Use and Disposable Devices

The market is seeing a significant move toward single-use and disposable gastrointestinal devices, such as biopsy forceps, snares, and even entire endoscopes. This trend is largely fueled by the heightened awareness of infection control, especially in the wake of the COVID-19 pandemic, when sterilization concerns became more prominent. Disposable devices eliminate the risk of cross-contamination between patients and reduce the need for complex reprocessing protocols, saving time and resources for healthcare facilities. Manufacturers are responding with cost-effective, eco-friendly disposable options to address environmental concerns.

Advanced Imaging Technologies

High-definition imaging has been a game-changer in gastrointestinal care, but the latest advancements go further with 3D visualization, multi-contrast laser imaging, and narrow-band imaging (NBI). These technologies allow physicians to see tissue structures in greater detail, improving the early detection of cancers, ulcers, and inflammatory conditions. Enhanced imaging tools can also guide therapeutic interventions during endoscopic procedures, leading to more precise and effective treatment.

Regulatory Approvals for Innovative Devices

Frequent FDA, CE Mark, and other regulatory approvals are accelerating the adoption of new gastrointestinal devices. Recent examples include the approval of the Rectal Expulsion Device (RED) for diagnosing chronic constipation and next-generation endoscopic submucosal dissection devices for removing complex lesions. These approvals not only expand the range of available treatments but also build physician confidence in adopting the latest technologies, given that they have passed rigorous safety and efficacy standards.

Gastrointestinal Devices Market Opportunities:

One compelling opportunity lies in the adoption of cutting-edge, incision-free surgical techniques—notably Natural Orifice Transluminal Endoscopic Surgery (NOTES) and Radiofrequency Ablation (RFA). Recently showcased by gastroenterologists in Nagpur, these techniques allow clinicians to operate through natural body orifices or apply targeted heat to eradicate early-stage lesions without external incisions. NOTES enables tumor removal and gallbladder surgery through the mouth or rectum, eliminating external scarring and reducing recovery times. RFA offers precision treatment of early esophageal and liver cancers by selectively destroying malignant tissue while preserving surrounding healthy areas. Capitalizing on these minimally invasive approaches can significantly expand the market—especially in regions where reducing hospital stays and surgical risks are top priorities.

Another high-impact opportunity lies in advancing AI-enhanced diagnostic technologies and gaining regulatory approvals to facilitate their global rollout. In mid-2024, Cosmo Intelligent Medical Devices earned FDA 510(k) clearance for its next-generation GI Genius™ hardware (6th generation), featuring enhanced AI-powered analytics, energy-efficient design, and multi-app integration via its new ColonPRO™ software for polyp detection and quality metric standardization. This regulatory milestone positions the platform to further penetrate markets worldwide. Manufacturers and healthcare providers stand to benefit by integrating such AI systems into standard endoscopic workflows, promoting earlier detection, procedural efficiency, and ultimately improved patient outcomes.

Gastrointestinal Devices Market Insights:

By Device Type: Endoscopy Devices Category Dominated the Global Gastrointestinal Devices Market

The market is bifurcated into device type, indication, end-user, and geography. On the basis of device type, the endoscopy devices dominate the global gastrointestinal devices market share, holding the largest portion due to their essential role in both diagnosis and therapeutic interventions for a wide range of digestive disorders. The rising prevalence of conditions such as colorectal cancer, inflammatory bowel disease (IBD), gastroesophageal reflux disease (GERD), and ulcers has significantly increased the demand for early detection and minimally invasive treatments—areas where endoscopy plays a central role. The growing use of colonoscopies, upper GI endoscopies, and capsule endoscopy procedures in outpatient and ambulatory settings has also boosted adoption. Furthermore, the integration of AI-assisted lesion detection, high-definition imaging, and narrow-band imaging technologies has enhanced diagnostic accuracy, further solidifying this segment’s leadership position.

Another key factor driving the dominance of endoscopy devices is the rapid pace of technological innovation and regulatory approvals, which encourage healthcare facilities to upgrade their equipment. The development of disposable endoscopes, robotic-assisted platforms, and advanced imaging modalities has expanded the scope of procedures that can be performed with minimal patient discomfort and shorter recovery times. Additionally, growing awareness campaigns about preventive GI health and national screening programs for colorectal cancer in countries such as the U.S., Japan, and several European nations are increasing the volume of endoscopic procedures worldwide. These combined factors ensure that the endoscopy devices segment remains at the forefront of the GI devices market for the foreseeable future.

By Indication: Colorectal Cancer Category Holds the Largest Gastrointestinal Devices Market Share in 2024

On the basis of indication, the market is further segmented into colorectal cancer, gastroesophageal reflux disease, inflammatory bowel disease, and others. The colorectal cancer accounts for the largest gastrointestinal devices market share in 2024, bolstered by its global prevalence and the increasing emphasis on early detection. As one of the most commonly diagnosed cancers worldwide, colorectal cancer continues to drive demand for advanced diagnostic and therapeutic devices. Screening programs—such as colonoscopy initiatives in the U.S., Japan, and Europe—boost utilization of endoscopes, biopsy tools, and polyp-removal equipment. The integration of AI-assisted colonoscopy platforms has further enhanced detection accuracy and efficiency, contributing to higher procedure volumes and reinforcing this segment’s leadership position within the market.

Adding to its momentum, a cutting-edge innovation has recently emerged: scientists in the U.K. have developed a tiny robot, shaped like a mussel shell and guided by an external magnet, which can navigate the digestive tract to perform 3D scans and potentially detect—and even treat—bowel (colorectal) cancer in a single procedure. After successful tests in pigs, human trials are planned for the near future. This groundbreaking technology represents a potentially transformative shift—streamlining diagnosis and treatment into one minimally invasive procedure, which could significantly expand reach, reduce barriers to screening, and further cement colorectal cancer’s pivotal role in shaping the future of the GI devices market.

The gastrointestinal devices market research report presents the analysis of each segment from 2020 to 2030 considering 2024 as the base year for the research. The compounded annual growth rate (CAGR) for each respective segment is calculated for the forecast period from 2025 to 2030.

Historical & Forecast Period

• 2020-23 – Historical Year
• 2024 – Base Year
• 2025-2030 – Forecast Period

Market Segmentation:

By Device Type:

• Endoscopy Devices
• GI Surgical Devices
• Bariatric Surgery Devices
• GI Hemostasis Devices
• GI Stent Devices
• Others

By Application:

• Colorectal Cancer
• Gastroesophageal Reflux Disease
• Inflammatory Bowel Disease
• Others

By End-User:

• Hospitals
• Ambulatory Surgical Centers & Independent Surgical Centers
• Clinics
• Others

By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Regional Analysis: North America Leads the Global Gastrointestinal Devices Market

Geographically, the North America dominated the global gastrointestinal devices market in 2024, driven by its advanced healthcare infrastructure, high prevalence of gastrointestinal disorders, and strong adoption of innovative medical technologies. The region benefits from widespread availability of skilled gastroenterologists, robust reimbursement systems, and an aging population that is more susceptible to conditions such as colorectal cancer, gastroesophageal reflux disease (GERD), and inflammatory bowel disease (IBD). High awareness levels and regular screening programs, especially for colorectal cancer, contribute to strong demand for advanced endoscopy systems, surgical instruments, and minimally invasive GI treatment options. The U.S., in particular, dominates regional growth due to its rapid adoption of AI-integrated diagnostic tools and continuous FDA approvals for new GI devices.

Furthermore, North America’s market leadership is reinforced by consistent technological innovation and strategic collaborations between medical device manufacturers and healthcare providers. Advancements in AI-based image analysis, improved capsule endoscopy technologies, and minimally invasive surgical tools are enhancing diagnostic accuracy and treatment outcomes. Such developments, combined with continuous R&D investments and favorable healthcare policies, position North America as a pioneer in next-generation GI device adoption. With a strong innovation ecosystem and proactive healthcare initiatives, the region is expected to maintain its dominance and serve as a global benchmark for gastrointestinal device advancements.

Competitive Landscape:

Some of the leading market players operating in the global gastrointestinal devices market are Medtronic plc, Olympus Corporation, Boston Scientific Corporation, CONMED Corporation, and Stryker. Companies are exploring markets by expansion, new investment, the introduction of new services, and collaboration as their preferred strategies. Players are exploring new geography through expansion and acquisition to gain a competitive advantage through joint synergy.

Key Companies:

• Medtronic plc
• Olympus Corporation
• Boston Scientific Corporation
• CONMED Corporation
• Stryker
• Johnson & Johnson (Ethicon, Inc.)
• FUJIFILM Holdings Corporation
• Cook Medical LLC
• STERIS plc
• Karl Storz SE & Co. KG
• Apollo Endosurgery, Inc.
• Others

Key Questions Answered by Gastrointestinal Devices Market Report

• Global gastrointestinal devices market forecasts from 2025-2030
• Regional market forecasts from 2025-2030 covering Asia-Pacific, North America, Europe, Middle East & Africa, and Latin America
• Country-level forecasts from 2025-2030 covering 15 major countries from the regions as mentioned above
• Gastrointestinal devices submarket forecasts from 2025-2030 covering the market by device type, indication, end-user, and geography
• Various industry models such as SWOT analysis, Value Chain Analysis about the market
• Analysis of the key factors driving and restraining the growth of the global, regional, and country-level gastrointestinal devices markets from 2025-2030
• Competitive Landscape and market positioning of top 10 players operating in the market